Michael Hart, MD
Michael Hart, MD is the medical director and founder at Readytogo Clinic in London, Ontario. Readytogo Clinic focuses on cannabinoid medicine, but also offers family medicine services, and specialized hormone testing.
Dr. Hart is a recognized speaker on the topic of cannabis. He has spoken at CME (Continuing Medical Education) events throughout Ontario, multiple cannabis conferences and has been featured on a variety of cannabis websites.
In February of 2018, Dr. Hart released “Friendly Fire: Why Vets Are Lighting Up And Ditching Pills to Treat PTSD” with his co-author Jeremy Kossen.
Dr. Hart has seen first-hand how the opioid epidemic is affecting our population and wanted to act by finding a solution. Dr. Hart believes that cannabis is an excellent alternative to opioids and has seen excellent results in his practice.
Education
In September 2002 Dr. Hart started studying nutritional biochemistry at Memorial University. He completed his degree in 2006. After receiving his undergraduate degree, he went on to obtain his medical degree at Saba School of Medicine in the Netherlands Antilles, where he studied between 2006 to 2010.
In 2010, Dr. Hart started his family medicine residency at the University of Western Ontario Schulich School of Medicine. He completed the program in 2012.
Skills and Interests
Dr. Hart’s primary focus has moved to closing the medical cannabis educational gap in the medical community. He was the first physician to open a cannabis clinic in London, Ontario. Building on the success that he had with treating patients by means of medical marijuana, he founded and opened the Readytogo Clinic in 2016.
He is also a member of PMC (Practitioners for Medicinal Marijuana), whose mission statement is written as follows: “PMC is a network of affiliated specialists and general practitioners committed to best possible patient care, including the informed use of cannabis and cannabis-derived medicines.”
Dr. Hart has substantial experience working exclusively with veterans. He uses cannabis primarily to treat PTSD, together with other alternative health care solutions.
